Skip to content

Evaluation of Carina Microphone Sensitivity and Maximum Stable Gain in Adult Recipients

A Prospective, Single-centre Evaluation of Carina Microphone Sensitivity and Maximum Stable Gain in Adult Recipients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04271761
Acronym
CAMSEN
Enrollment
14
Registered
2020-02-17
Start date
2020-02-11
Completion date
2020-02-21
Last updated
2021-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Impairment

Keywords

cochlear implantation

Brief summary

This investigation is a single-centre, prospective, single-arm, post-market, non-interventional, pilot clinical investigation designed to characterize microphone sensitivity and maximum stable gain of the Cochlear Carina System.

Detailed description

The totally implanted Carina System is an active middle ear implant where all components are implanted under the skin. Placing a microphone under the skin affects its acoustic sensitivity and vibration sensitivity. Software is now available to enable non-intrusive microphone measurements in existing patients with the Carina device, through a wireless link to the implant. Detailed knowledge of the acoustic sensitivity of the implanted microphone and objectively measured maximum stable gain, and its inter-individual variability, will allow more accurate calculation of overall system performance, and thereby more accurate prediction of clinical outcomes. Subjects will attend one scheduled study visit to be assessed; several objective acoustic measurements will be performed that do not require active participation from the subject. No data monitoring committee will be used for this clinical investigation.

Interventions

OTHERNon-interventional, post-market, pilot study of Carina Cochlear System

Several objective acoustic measurements will be performed that do not require active participation from the subject.

Sponsors

Cochlear
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Eighteen years of age or older at the time of enrolment in the study * Current recipient of a Cochlear Carina System.

Exclusion criteria

\- Unwillingness or inability of the candidate to comply with all investigational requirements as determined by the Investigator.

Design outcomes

Primary

MeasureTime frameDescription
Acoustic Sensitivity of Implanted Carina Microphonefrom date of enrolment through to study visit, an average of 1 monthThe acoustic sensitivity of the implanted microphone was measured using a white noise acoustic test signal was presented from a loudspeaker, with the sound pressure level monitored with an external probe microphone positioned over the location of the implanted microphone and the signal level at the implanted microphone recorded through a wireless link to the Carina implant.
Ratio of Response of Carina Microphone : Accelerometer for Acoustic Stimulationfrom date of enrolment through to study visit, an average of 1 monthRatio \[dB\] of response of implanted microphone to response of implanted accelerometer, in-situ, for audiometric frequencies 250-6000 Hz, median and percentiles
Carina Maximum Stable Gainfrom date of enrolment through to study visit, an average of 1 monthTransfer function from Carina output to actuator \[dB FS\] to Carina input from implanted microphone \[dB FS\], for audiometric frequencies 250-6000 Hz, with ear canal open and ear canal plugged.
Carina Microphone Impulse Response for Acoustic and Actuator Stimulationfrom date of enrolment through to study visit, an average of 1 monthIdentification of the system's acoustic and vibration transfer functions including non-linear components.

Countries

Portugal

Participant flow

Participants by arm

ArmCount
Current Adult Recipients of Cochlear Carina System
Adults who are current recipients of the Cochlear Carina System. Participants will attend one scheduled visit where several acoustic measurements will be taken that do not require active participation by the participant. Non-interventional, post-market, pilot study of Carina Cochlear System: Several objective acoustic measurements will be performed that do not require active participation from the subject.
14
Total14

Baseline characteristics

CharacteristicCurrent Adult Recipients of Cochlear Carina System
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
8 Participants
Age, Categorical
Between 18 and 65 years
6 Participants
Age, Continuous62.4 Years
STANDARD_DEVIATION 15.1
Ear (Left/Right)
Left Ear
6 Participants
Ear (Left/Right)
Right Ear
8 Participants
Microphone Position
A-B
1 Participants
Microphone Position
A-mastoid tip
0 Participants
Microphone Position
B-C
0 Participants
Microphone Position
B-posterior inferior
1 Participants
Microphone Position
C-D
1 Participants
Microphone Position
C-posterior mastoid
9 Participants
Microphone Position
D-posterior
1 Participants
Microphone Position
E-posterior superior
0 Participants
Microphone Position
Unknown
1 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Portugal
14 participants
Sex: Female, Male
Female
5 Participants
Sex: Female, Male
Male
9 Participants
Type of HL, coupling
Mixed HL, power stapes
1 Participants
Type of HL, coupling
Mixed HL, stapes head
6 Participants
Type of HL, coupling
Sensorineural HL. incus
7 Participants
Usage(years)3.1 years
STANDARD_DEVIATION 1.3

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 14
other
Total, other adverse events
0 / 14
serious
Total, serious adverse events
0 / 14

Outcome results

Primary

Acoustic Sensitivity of Implanted Carina Microphone

The acoustic sensitivity of the implanted microphone was measured using a white noise acoustic test signal was presented from a loudspeaker, with the sound pressure level monitored with an external probe microphone positioned over the location of the implanted microphone and the signal level at the implanted microphone recorded through a wireless link to the Carina implant.

Time frame: from date of enrolment through to study visit, an average of 1 month

ArmMeasureValue (MEDIAN)
Current Adult Recipients of Cochlear Carina SystemAcoustic Sensitivity of Implanted Carina Microphone-64 dB
Primary

Carina Maximum Stable Gain

Transfer function from Carina output to actuator \[dB FS\] to Carina input from implanted microphone \[dB FS\], for audiometric frequencies 250-6000 Hz, with ear canal open and ear canal plugged.

Time frame: from date of enrolment through to study visit, an average of 1 month

ArmMeasureGroupValue (MEDIAN)
Current Adult Recipients of Cochlear Carina SystemCarina Maximum Stable GainEar Canal Open33.2 dB
Current Adult Recipients of Cochlear Carina SystemCarina Maximum Stable GainEar Canal plugged0.3 dB
Primary

Carina Microphone Impulse Response for Acoustic and Actuator Stimulation

Identification of the system's acoustic and vibration transfer functions including non-linear components.

Time frame: from date of enrolment through to study visit, an average of 1 month

ArmMeasureGroupValue (NUMBER)
Current Adult Recipients of Cochlear Carina SystemCarina Microphone Impulse Response for Acoustic and Actuator StimulationPresence of Vibration0 participants
Current Adult Recipients of Cochlear Carina SystemCarina Microphone Impulse Response for Acoustic and Actuator StimulationPresence of distortion0 participants
Primary

Ratio of Response of Carina Microphone : Accelerometer for Acoustic Stimulation

Ratio \[dB\] of response of implanted microphone to response of implanted accelerometer, in-situ, for audiometric frequencies 250-6000 Hz, median and percentiles

Time frame: from date of enrolment through to study visit, an average of 1 month

ArmMeasureValue (MEDIAN)
Current Adult Recipients of Cochlear Carina SystemRatio of Response of Carina Microphone : Accelerometer for Acoustic Stimulation16.7 MAR (Microphone : Accelerometer ratio)

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026